Unnamed: 0,title,date,stock,sentiment
967177.0,OraSure Technologies shares are trading higher after the company announced it received $629K in BARDA funding for coronavirus antibody ELISA using oral fluid samples.,2020-06-10 09:59:00-04:00,OSUR,positive
967178.0,OraSure Technologies Reports Received $629K In BARDA Funding For Coronavirus Antibody ELISA Using Oral Fluid Samples,2020-06-10 08:10:00-04:00,OSUR,neutral
967179.0,OraSure's Oragene•Dx Included In EUA Allowing At-Home Saliva Collection For Use With Phosphorus SARS-CoV-2 Test,2020-06-08 08:18:00-04:00,OSUR,neutral
967180.0,OraSure's Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test,2020-06-08 08:10:00-04:00,OSUR,neutral
967181.0,OraSure Technologies Yesterday Announces Exercise of Option to Purchase Additional Shares of Common Stock,2020-06-04 08:39:00-04:00,OSUR,positive
967182.0,OraSure Technologies shares are trading lower after the company priced its underwritten offering of 8 million shares of common stock at $11 per share.,2020-06-03 07:18:00-04:00,OSUR,positive
967183.0,OraSure Technologies  Prices 8M Share Underwritten Offering of Common Stock @$11/Share,2020-06-03 05:47:00-04:00,OSUR,positive
967184.0,72 Biggest Movers From Yesterday,2020-06-03 05:11:00-04:00,OSUR,neutral
967185.0,50 Stocks Moving In Tuesday's Mid-Day Session,2020-06-02 12:21:00-04:00,OSUR,neutral
967186.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,OSUR,negative
967187.0,33 Stocks Moving in Tuesday's Pre-Market Session,2020-06-02 07:04:00-04:00,OSUR,neutral
967188.0,A Peek Into The Markets: US Stock Futures Up; Crude Oil Rises Over 2%,2020-06-02 06:03:00-04:00,OSUR,negative
967189.0,"6 Stocks To Watch For June 2, 2020",2020-06-02 04:08:00-04:00,OSUR,neutral
967190.0,OraSure Technologies Reports 8M Share Common Stock Offering,2020-06-01 16:01:00-04:00,OSUR,positive
967191.0,OraSure Reports Purchase Of UrSure For $3M In Upfront Cash,2020-05-29 07:08:00-04:00,OSUR,neutral
967192.0,OraSure Technologies shares are trading higher after the company announced its OMNIgene ORAL kit was included in the FDA's EUA granted to P23 Labs for at-home collection of saliva samples for the detection of SARS-CoV-2.,2020-05-22 09:35:00-04:00,OSUR,positive
967193.0,OraSure Announces OMNIgene·ORAL Kit Included In EUA Granted To P23 Labs For At-Home Collection Of Saliva Samples For SARS-CoV-2 Coronavirus Test,2020-05-22 07:03:00-04:00,OSUR,positive
967194.0,OraSure Reports Will Consolidate All Microbiome Services Under Diversigen Brand,2020-05-12 08:09:00-04:00,OSUR,neutral
967195.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,OSUR,negative
967196.0,Stocks That Hit 52-Week Highs On Monday,2020-05-11 10:28:00-04:00,OSUR,neutral
967197.0,Stocks That Hit 52-Week Highs On Friday,2020-05-08 10:32:00-04:00,OSUR,neutral
967198.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,OSUR,negative
967199.0,"OraSure Technologies Q1 EPS $(0.120) Misses $(0.060) Estimate, Sales $31.600M Beat $29.230M Estimate",2020-05-06 16:03:00-04:00,OSUR,negative
967200.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,OSUR,positive
967201.0,OraSure Technologies' ORAcollect·RNA Kit Included in an Emergency Use Authorization Granted to Biocerna for Coronavirus,2020-05-04 06:25:00-04:00,OSUR,negative
967202.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,OSUR,neutral
967203.0,"The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda",2020-04-29 08:40:00-04:00,OSUR,positive
967204.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-28 10:18:00-04:00,OSUR,neutral
967205.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,OSUR,neutral
967206.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,OSUR,positive
967207.0,Stocks That Hit 52-Week Highs On Thursday,2020-04-23 10:41:00-04:00,OSUR,neutral
967208.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,OSUR,negative
967209.0,Shares of several healthcare companies are trading higher as equities gain amid oil prices potentially stabilizing following the recent crash.,2020-04-22 12:03:00-04:00,OSUR,positive
967210.0,"The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership",2020-04-22 07:51:00-04:00,OSUR,negative
967211.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-21 10:30:00-04:00,OSUR,neutral
967212.0,"The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives",2020-04-21 08:19:00-04:00,OSUR,positive
967213.0,Stocks That Hit 52-Week Highs On Monday,2020-04-20 10:25:00-04:00,OSUR,neutral
967214.0,Stocks That Hit 52-Week Highs On Friday,2020-04-17 10:19:00-04:00,OSUR,neutral
967215.0,"The Daily Biotech Pulse: Moderna Secures $483M In BARDA Funding, Gilead Remdesivir Data, Veracyte's Positive Pre-Announcement",2020-04-17 07:35:00-04:00,OSUR,positive
967216.0,70 Biggest Movers From Yesterday,2020-04-17 04:53:00-04:00,OSUR,neutral
967217.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-14 10:31:00-04:00,OSUR,neutral
967218.0,84 Biggest Movers From Yesterday,2020-04-07 05:47:00-04:00,OSUR,neutral
967219.0,66 Stocks Moving In Monday's Mid-Day Session,2020-04-06 12:32:00-04:00,OSUR,neutral
967220.0,OraSure Technologies shares are trading higher after the company announced it received a government contract for rapid oral fluid Pan-SARS-Coronavirus self-test.,2020-04-06 07:42:00-04:00,OSUR,positive
967221.0,OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test,2020-04-06 06:12:00-04:00,OSUR,neutral
967222.0,80 Biggest Movers From Yesterday,2020-03-31 04:15:00-04:00,OSUR,neutral
967223.0,144 Biggest Movers From Friday,2020-03-16 05:03:00-04:00,OSUR,neutral
967224.0,"Orasure Shares Up 23%; Traders Attributing Move Higher As Sympathy Play On Coronavirus, Highlight Co. Owns DNA Genotek Which Was Given FDA Clearance On Jan. 22 For Oragene, Non-Invasive Collection Of Saliva Samples BZ NOTE: Release Didn't Specifically Mention Coronavirus",2020-03-13 15:04:00-04:00,OSUR,positive
967225.0,Stocks That Hit 52-Week Lows On Friday,2020-03-13 11:13:00-04:00,OSUR,negative
967226.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,OSUR,negative
967227.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,OSUR,negative
967228.0,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion",2020-02-21 07:46:00-05:00,OSUR,negative
967229.0,95 Biggest Movers From Yesterday,2020-02-21 05:12:00-05:00,OSUR,neutral
967230.0,71 Stocks Moving In Thursday's Mid-Day Session,2020-02-20 12:16:00-05:00,OSUR,neutral
967231.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-20 10:54:00-05:00,OSUR,negative
967232.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,OSUR,negative
967233.0,"OraSure Technologies Q4 EPS $0.04 Misses $0.07 Estimate, Sales $49.668M Beat $47.03M Estimate",2020-02-19 16:01:00-05:00,OSUR,negative
967234.0,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",2020-02-19 07:21:00-05:00,OSUR,negative
967235.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",2020-02-16 15:03:00-05:00,OSUR,positive
967236.0,OraSure Subsidiary DNA Genotek Announces FDA General Use Clearance For Oragene·Dx Family Of Products,2020-01-22 06:04:00-05:00,OSUR,neutral
967237.0,"OraSure Technologies Q3 EPS $0.21 Beats $0.09 Estimate, Sales $35.989M Miss $38.62M Estimate",2019-11-06 16:14:00-05:00,OSUR,negative
967238.0,OraSure Technologies Acquires Diversigen for $12M Cash,2019-11-06 16:11:00-05:00,OSUR,neutral
967239.0,"OraSure Technologies Reports Purchase Of Diversigen, No Terms Disclosed",2019-11-06 16:00:00-05:00,OSUR,negative
967240.0,US FDA Granted Marketing Authorization Of The Oraquick Ebola Test To Orasure Technologies Inc,2019-10-10 14:03:00-04:00,OSUR,positive
967241.0,Stocks That Hit 52-Week Lows On Friday,2019-08-23 11:08:00-04:00,OSUR,negative
967242.0,OraSure to Sell its Cryosurgical Systems Business to CryoConcepts for $12M Cash,2019-08-19 08:06:00-04:00,OSUR,neutral
967243.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,OSUR,negative
967244.0,"OraSure Technologies Q2 EPS $0.07 Beats $0.02 Estimate, Sales $38.826M Miss $41.48M Estimate",2019-08-06 16:03:00-04:00,OSUR,negative
967245.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,OSUR,negative
967246.0,"Canaccord Genuity Downgrades OraSure Technologies, Inc. - Common Stock to Hold",2019-05-09 07:21:00-04:00,OSUR,neutral
967247.0,"OraSure Technologies, Inc. - Common Stock Sees FY2019 EPS $0.22-0.24 vs $0.22 Est; Sees Sales $170M-175M vs $172.79M Est",2019-05-08 16:23:00-04:00,OSUR,neutral
967248.0,"OraSure Technologies, Inc. - Common Stock Sees Q2 EPS $0.02 vs $0.03 Est; Sees Sales $40M-42M vs $40.37M Est",2019-05-08 16:22:00-04:00,OSUR,neutral
967249.0,"OraSure Technologies Q1 EPS $(0.05) Beats $(0.06) Estimate, Sales $30.122M Beat $29.85M Estimate",2019-05-08 16:21:00-04:00,OSUR,neutral
967250.0,66 Biggest Movers From Friday,2019-02-11 04:33:00-05:00,OSUR,neutral
967251.0,48 Stocks Moving In Friday's Mid-Day Session,2019-02-08 12:42:00-05:00,OSUR,neutral
967252.0,72 Biggest Movers From Yesterday,2019-02-08 05:18:00-05:00,OSUR,neutral
967253.0,54 Stocks Moving In Thursday's Mid-Day Session,2019-02-07 12:28:00-05:00,OSUR,neutral
967254.0,"OraSure Technologies shares are trading lower after the company reported FY18 international sales of its OraQuick HCV product decreased 71% since 2017, and Q4 net product revenue decreased 11% since last year.",2019-02-07 08:42:00-05:00,OSUR,neutral
967255.0,26 Stocks Moving In Thursday's Pre-Market Session,2019-02-07 08:10:00-05:00,OSUR,neutral
967256.0,"OraSure Technologies shares are trading lower after the company reported FY18 international sales of its OraQuick HCV product decreased 71% since 2017, and Q4 net product revenue decreased 11% since last year.",2019-02-06 17:27:00-05:00,OSUR,neutral
967257.0,8 Stocks Moving In Wednesday's After-Hours Session,2019-02-06 17:00:00-05:00,OSUR,neutral
967258.0,"OraSure Technologies Q4 EPS $0.16 Beats $0.11 Estimate, Sales $50.2M Beat $47.8M Estimate",2019-02-06 16:01:00-05:00,OSUR,neutral
967259.0,"OraSure Reports 2 Purchases: CoreBiome, Novosanis, No Terms Disclosed",2019-01-04 07:06:00-05:00,OSUR,negative
967260.0,"OraSure Reaffirms Q4 Guidance: EPS $0.09-$0.11 vs $0.11 Estimate, Sales $46.5M-$48M vs $47.7M Est.",2019-01-04 07:06:00-05:00,OSUR,neutral
967261.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,OSUR,neutral
967262.0,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",2018-12-20 07:53:00-05:00,OSUR,positive
967263.0,OraSure Technologies S-3 Shows Filing For $300M Mixed Shelf Offering,2018-12-18 16:37:00-05:00,OSUR,neutral
967264.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018",2018-12-10 11:01:00-05:00,OSUR,negative
967265.0,"The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",2018-11-09 07:32:00-05:00,OSUR,neutral
967266.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,OSUR,negative
967267.0,OraSure Technologies Sees FY2018 EPS $0.09-0.11; Sees Sales $46.50M-48.0M vs $54.59M Est,2018-11-07 16:13:00-05:00,OSUR,neutral
967268.0,"OraSure Technologies, Inc. Q3 EPS $0.13 Beats $0.11 Estimate, Sales $45.885M Beat $44.51M Estimate",2018-11-07 16:12:00-05:00,OSUR,neutral
967269.0,"OraSure Sees Q3 EPS $0.10-$0.12 vs $0.11 Est., Sales $44M-$45.5M vs $44.17M Est.",2018-08-08 17:26:00-04:00,OSUR,neutral
967270.0,"OraSure Technologies Q2 EPS $0.07 Beats $0.04 Estimate, Sales $43.6M Beat $42.23M Estimate",2018-08-08 17:25:00-04:00,OSUR,neutral
967271.0,40 Biggest Movers From Yesterday,2018-07-17 04:50:00-04:00,OSUR,neutral
967272.0,31 Stocks Moving In Monday's Mid-Day Session,2018-07-16 12:25:00-04:00,OSUR,neutral
967273.0,"Benzinga's Top Upgrades, Downgrades For July 16, 2018",2018-07-16 09:03:00-04:00,OSUR,positive
967274.0,Stephens & Co. Downgrades OraSure Technologies to Equal-Weight,2018-07-16 07:21:00-04:00,OSUR,neutral
967275.0,OraSure Technologies Reports CFO Ronald Spair To Retire; Roberto Cuca Named Replacement,2018-05-04 06:12:00-04:00,OSUR,neutral
967276.0,OraSure Technologies Names Roberto Cuca CFO,2018-05-04 06:09:00-04:00,OSUR,neutral
967277.0,55 Biggest Movers From Yesterday,2018-05-04 04:41:00-04:00,OSUR,neutral
967278.0,37 Stocks Moving In Thursday's Mid-Day Session,2018-05-03 13:39:00-04:00,OSUR,neutral
967279.0,"OraSure Shares Down 17.2%; Co. Late Wednesday Reported Q1 EPS $(0.03) Beat $(0.06) Est., Sales $41.99M Beat $40.6M Est.",2018-05-03 10:56:00-04:00,OSUR,positive
967280.0,"13F From Perceptive Advisors Late Wednesday Shows Increased Stake In Abiomed, Neurocrine Biosciences, VBI Vaccines; New Stake In Agile Therapeutics, Amgen, bluebird bio, Arena Pharma, Revance Therapeutics; Exited Stake In Achaogen, OraSure Technologies",2018-02-15 10:41:00-05:00,OSUR,positive
967281.0,"OraSure Technologies Reports Q4 EPS $0.12 vs $0.11 Est., Sales $52M vs $47.8M Est.",2018-02-07 16:01:00-05:00,OSUR,neutral
967282.0,Orasure Sees Q4 Sales Higher Than Previously Projected An Sees Net. Sales Of At Least $50M,2018-01-04 06:04:00-05:00,OSUR,neutral
967283.0,"OraSure Names Dr. Stephen Tang CEO Effective April 1st To Replace Douglas Michels Who Is Retiring, CFO & COO Ronald Spair To Also Retire",2018-01-04 06:03:00-05:00,OSUR,positive
967284.0,Orasure Option Alert: Jul 20 $15 Puts Sweep (3) at the Ask: 948 @ $1.101 vs 7 OI; Ref=$18.72; Jul 20 $20 Puts Sweep (4) at the Bid: 858 @ $3.601 vs 0 OI; Ref=$18.7,2017-12-28 15:00:00-05:00,OSUR,positive
967285.0,"Jefferies Out Negative On OraSure, Says It's Unclear How Much Of $143M Consumer Genomics Contract Is Truly Incremental To Its Current Run-Rate",2017-11-22 10:37:00-05:00,OSUR,negative
967286.0,32 Stocks Moving In Wednesday's Pre-Market Session,2017-11-22 08:05:00-05:00,OSUR,neutral
967287.0,40 Biggest Movers From Yesterday,2017-11-22 05:03:00-05:00,OSUR,neutral
967288.0,OraSure Shares Spike 5% Higher Following 8-K Showing Co. Subsidiary DNAG Genotek Entered Into $143M Deal For Supply Of Oragene Dx Devices To Leading Consumer Genomics Customer,2017-11-21 13:44:00-05:00,OSUR,negative
967289.0,66 Biggest Movers From Yesterday,2017-11-03 04:49:00-04:00,OSUR,neutral
967290.0,52 Stocks Moving In Thursday's Mid-Day Session,2017-11-02 12:29:00-04:00,OSUR,neutral
967291.0,"The Market In 5 Minutes: Facebook, Tesla In The Red As Market Preps For Apple's Latest Earnings",2017-11-02 08:48:00-04:00,OSUR,neutral
967292.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-11-02 08:25:00-04:00,OSUR,neutral
967293.0,Jefferies Downgrades OraSure Technologies to Hold,2017-11-02 07:19:00-04:00,OSUR,neutral
967294.0,"OraSure Sees Q4 EPS $0.08 to $0.09 vs $0.08 Est., Sales $45M to $46M vs $40M Est.",2017-11-01 16:27:00-04:00,OSUR,neutral
967295.0,"OraSure Q3 EPS $0.09 vs $0.09 Est., Sales $42.3M vs $40.8M Est.",2017-11-01 16:27:00-04:00,OSUR,neutral
967296.0,"OraSure Sees Q4 EPS $0.08-$0.09 vs $0.08 Est., Sales $45M-$46M vs $39.76M Est.",2017-11-01 16:02:00-04:00,OSUR,neutral
967297.0,"OraSure Reports Q3 EPS $0.09 In-line With Est., Sales $42.3M vs $40.83M Est.",2017-11-01 16:02:00-04:00,OSUR,neutral
967298.0,20 Biggest Mid-Day Gainers For Thursday,2017-08-03 12:27:00-04:00,OSUR,neutral
967299.0,"OraSure Technologies Sees Q3 EPS $0.09-$0.10 vs $0.08 Est., Sales $40.5M-$41.5M vs $37.55M Est.",2017-08-02 16:29:00-04:00,OSUR,neutral
967300.0,"OraSure Technologies Reports Q2 EPS $0.09 vs $0.07 Est., Sales $40.2M vs $36.55M Est.",2017-08-02 16:28:00-04:00,OSUR,neutral
967301.0,OraSure Technologies Receives WHO Prequalification of OraQuick HIV Self-Test,2017-07-21 07:08:00-04:00,OSUR,neutral
967303.0,"OraSure Shares Up 9% For The Session, Quiet Over Last Few Mins Amid Raised Price Target By Jefferies, From $16 To $19",2017-06-27 15:01:00-04:00,OSUR,positive
967304.0,Gates Foundation Deal Opens Things Up For OraSure,2017-06-27 14:07:00-04:00,OSUR,neutral
967305.0,"Canaccord Out Positive On OraSure Technologies Following 4-Year $20M Agreement With The Bill & Melinda Gates Foundation Which Will Subsidize Cost Of OraSure's HIV Self Test, Raises Price Target From $15 to $18",2017-06-27 11:14:00-04:00,OSUR,positive
967306.0,"OraSure Technologies Reports Q1 EPS $0.21 vs $0.18 Est., Sales $32.5M vs $31.23M Est.",2017-05-03 16:39:00-04:00,OSUR,neutral
967307.0,10 Biggest Mid-Day Gainers For Tuesday,2017-03-21 12:40:00-04:00,OSUR,neutral
967308.0,S&P Dow Jones Indices Announces 'OraSure Technologies and John B. Sanfilippo & Son Set to Join S&P SmallCap 600',2017-03-20 17:18:00-04:00,OSUR,positive
967309.0,Mid-Afternoon Market Update: Dun & Bradstreet Drops On Earnings Miss; OraSure Shares Surge,2017-02-09 14:35:00-05:00,OSUR,positive
967310.0,20 Biggest Mid-Day Gainers For Thursday,2017-02-09 12:31:00-05:00,OSUR,neutral
967311.0,Mid-Day Market Update: Dow Rises Over 100 Points; Vista Outdoor Shares Slide,2017-02-09 12:06:00-05:00,OSUR,positive
967312.0,"Benzinga's Top Upgrades, Downgrades For February 9, 2017",2017-02-09 09:48:00-05:00,OSUR,positive
967313.0,Raymond James Upgrades OraSure Technologies To Outperform,2017-02-09 06:45:00-05:00,OSUR,neutral
967314.0,"OraSure Reports Q4 EPS $0.13 vs. Est. $0.06, Rev. $35.49M vs. Est. $34.8M",2017-02-08 16:01:00-05:00,OSUR,neutral
967315.0,OraSure Tech to Receive $12.5M From Ancestry.com for Patent Settlement,2017-02-06 06:08:00-05:00,OSUR,neutral
967316.0,"Benzinga's Top Upgrades, Downgrades For December 21, 2016",2016-12-21 09:22:00-05:00,OSUR,positive
967317.0,"CL King Initiates Coverage On OraSure Technologies at Buy, Announces $11.00 Target",2016-12-21 08:17:00-05:00,OSUR,neutral
967318.0,OraSure Announces 2 Contracts,2016-11-29 06:10:00-05:00,OSUR,neutral
967319.0,7 Stocks That Rallied Three Days On Increasing Volume,2016-11-21 12:15:00-05:00,OSUR,neutral
967320.0,Canaccord Genuity Medical Technology And Diagnostics Forum Today,2016-11-17 09:56:00-05:00,OSUR,neutral
967321.0,"Orasure Technologies Names Stephen S. Tang, Ph.d. as Chairman",2016-11-15 06:03:00-05:00,OSUR,neutral
967322.0,"OraSure Sees Q4 Rev. $34.5-$35.25M vs. Est. $35.18M, EPS $0.05-$0.06 vs. Est. $0.09",2016-11-02 16:23:00-04:00,OSUR,neutral
967323.0,"OraSure Reports Q3 EPS $0.11 vs. Est. $0.07, Rev. $32.3M vs. Est. $31.45M",2016-11-02 16:23:00-04:00,OSUR,neutral
967324.0,8 Biggest Mid-Day Losers For Monday,2016-09-19 12:50:00-04:00,OSUR,negative
967325.0,Mid-Morning Market Update: Markets Open Higher; Tech Data To Buy Technology Solutions From Avnet,2016-09-19 10:03:00-04:00,OSUR,positive
967326.0,Benzinga's Top Downgrades,2016-09-19 09:08:00-04:00,OSUR,positive
967327.0,BTIG Downgrades OraSure Technologies To Neutral Citing Valuation,2016-09-19 08:36:00-04:00,OSUR,neutral
967328.0,"BTIG Research Downgrades OraSure Technologies to Neutral, Removes $8.00 PT",2016-09-19 06:01:00-04:00,OSUR,neutral
967329.0,How The Zika Virus Spread While Congress Was Out On Recess,2016-09-02 09:29:00-04:00,OSUR,neutral
967330.0,"15 Stocks Which Rallied Four Days, Then Sold Off Yesterday",2016-08-31 13:17:00-04:00,OSUR,neutral
967331.0,4 Zika-Related Stocks Surging Today,2016-08-29 13:13:00-04:00,OSUR,neutral
967332.0,Stephens & Co. Upgrades OraSure Technologies to Overweight,2016-08-29 09:00:00-04:00,OSUR,negative
967333.0,OraSure Technologies Announces DNA Genotek's OMNIgene GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome,2016-08-29 06:05:00-04:00,OSUR,neutral
967334.0,"UPDATE: FDA Advises Testing for Zika Virus in All Donated Blood, Blood Components in U.S.",2016-08-26 10:43:00-04:00,OSUR,neutral
967335.0,"OraSure Gets Zika Contract, Canaccord Raises Price Target",2016-08-24 15:55:00-04:00,OSUR,neutral
967336.0,18 Biggest Mid-Day Gainers For Wednesday,2016-08-24 12:56:00-04:00,OSUR,neutral
967337.0,Orasure Spikes to High of $8.20 on Volume,2016-08-24 10:33:00-04:00,OSUR,neutral
967338.0,14 Stocks Moving In Wednesday's Pre-Market Session,2016-08-24 08:28:00-04:00,OSUR,neutral
967339.0,6 Stocks Moving After Hours: From Earnings To Government Contracts,2016-08-23 17:51:00-04:00,OSUR,neutral
967340.0,"CORRECTION: OraSure Ticker is 'OSUR,' Not 'ORA'",2016-08-23 16:04:00-04:00,OSUR,neutral
967341.0,"OraSure Sees Q3 Rev. $31.25-$31.75M vs. Est. $34.5M, EPS $0.07-$0.08 vs. Est. $0.08",2016-08-03 16:16:00-04:00,OSUR,neutral
967342.0,"OraSure Reports Q2 EPS $0.07 vs. Est. $0.05, Rev. $31.4M vs. Est. $31.1M",2016-08-03 16:16:00-04:00,OSUR,neutral
967343.0,10 Stocks Moving In Friday's Pre-Market Session,2016-07-01 08:29:00-04:00,OSUR,neutral
967344.0,OraSure Technologies and AbbVie Agree to an Early Termination of HCV Co-Promotion Agreement,2016-07-01 06:01:00-04:00,OSUR,positive
967345.0,OraSure Shares Down ~3.5%; Traders Passing Around SeekingAlpha Article from Rick Pearson 'Expect OraSure To Drop 35% (Or More) Next Week',2016-06-30 09:49:00-04:00,OSUR,neutral
967346.0,7 Biggest Mid-Day Losers For Monday,2016-06-13 13:20:00-04:00,OSUR,negative
967347.0,Mid-Day Market Update: Smith & Wesson Rises Following Orlando Shootings on Sunday; BioScrip Shares Slide,2016-06-13 12:07:00-04:00,OSUR,positive
967348.0,"Raymond James Sees 'Lingering Risks' At OraSure, Downgrades To Market Perform",2016-06-13 10:11:00-04:00,OSUR,negative
967349.0,Mid-Morning Market Update: Markets Edge Lower; Microsoft To Acquire LinkedIn For $26 Billion,2016-06-13 09:58:00-04:00,OSUR,negative
967350.0,Raymond James Downgrades OraSure Technologies to Market Perform,2016-06-13 06:06:00-04:00,OSUR,neutral
967351.0,"EARLIER: OraSure Sees Q2 Sales $30.5M-$31.5M vs $32M Est., EPS $0.04-$0.05 vs $0.05 Est.",2016-05-04 18:36:00-04:00,OSUR,neutral
967352.0,"OraSure Technologies Reports Q1 EPS $0.04 vs $0.02 Est., Sales $29.1M vs $28.8M Est.",2016-05-04 16:39:00-04:00,OSUR,neutral
967353.0,OraSure Technologies Hires Michael Reed As Chief Scientific Officer,2016-04-15 07:26:00-04:00,OSUR,neutral
967354.0,"OraSure Reports Q4 EPS $0.08 vs. Est. $0.03, Rev. $32.4M vs. Est. $29.73M",2016-02-03 16:48:00-05:00,OSUR,neutral
967355.0,S-3 from OraSure Shows Registration for $200M Mixed Securities Shelf Offering,2015-12-11 17:05:00-05:00,OSUR,positive
967356.0,"Early Global News: Ebola In Liberia, Boeing To Roll Out 737 MAX Next Month, Google Testing SMS Alerts",2015-11-25 07:57:00-05:00,OSUR,neutral
967357.0,"Early Global News: Mali Radisson Attack, Depomed-Horizon Fallout, EU Cracking Down On Bitcoin",2015-11-20 09:37:00-05:00,OSUR,negative
967358.0,"OraSure Technologies Reports Q2 EPS $0.03 Vs Est $0.01, Sales $30.4M Vs Est $28.95M; Sees Q3 Loss $0.01-$0.00 Vs Est $0.00 & Revs $29.5M-$30M Vs Est $29.34M",2015-08-05 17:37:00-04:00,OSUR,negative
967359.0,Morning Market Gainers,2015-08-03 09:37:00-04:00,OSUR,neutral
967360.0,Benzinga's Top #PreMarket Gainers,2015-08-03 08:19:00-04:00,OSUR,positive
967361.0,US Stock Futures Flat Ahead Of Economic Data,2015-08-03 07:17:00-04:00,OSUR,neutral
967362.0,Orasure Announces FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test,2015-08-03 06:03:00-04:00,OSUR,negative
967363.0,Morning Market Gainers,2015-06-12 09:49:00-04:00,OSUR,neutral
967364.0,Benzinga's Top #PreMarket Gainers,2015-06-12 08:20:00-04:00,OSUR,positive
967365.0,OraSure Announces Winning of $10.4M HHS Contract for Rapid Advancement of Ebola Test Clinical Development,2015-06-12 07:31:00-04:00,OSUR,positive
967366.0,Hear OraSure Shares have been Moving on PR from 2013,2015-05-19 09:33:00-04:00,OSUR,positive
967367.0,Benzinga's Top #PreMarket Gainers,2015-05-19 08:08:00-04:00,OSUR,positive
967368.0,Morning Market Gainers,2015-05-18 09:42:00-04:00,OSUR,neutral
967369.0,Benzinga's Top #PreMarket Gainers,2015-05-18 08:16:00-04:00,OSUR,positive
967370.0,"BSQUARE, OraSure Technologies, Avon Products Lead Thursday's After-Hours Movers",2015-05-14 17:57:00-04:00,OSUR,neutral
967371.0,Morning Market Losers,2015-05-07 10:02:00-04:00,OSUR,negative
967372.0,Benzinga's Top Downgrades,2015-05-07 09:49:00-04:00,OSUR,positive
967373.0,JMP Securities Downgrades OraSure Technologies To  Market Perform,2015-05-07 08:26:00-04:00,OSUR,positive
967374.0,JMP Securities Downgrades OraSure Technologies to Market Perform,2015-05-07 04:20:00-04:00,OSUR,positive
967375.0,Jefferies: 10 Buyout Targets To Own During The M&A Boom,2015-04-13 16:17:00-04:00,OSUR,neutral
967377.0,"OraSure Technologies Reports Q4 EPS Loss $0.05 Vs Est Loss $0.04, Revs $28.7M Vs Est $28.22M",2015-02-04 16:04:00-05:00,OSUR,negative
967378.0,Jefferies Raises OraSure Technologies Price Target,2014-12-31 09:08:00-05:00,OSUR,neutral
967379.0,"OraSure Technologies, Inc. Reports Q3 EPS of $0.02 vs $(0.05) Est; Revenue of $27.80M vs $27.17M Est",2014-11-05 16:36:00-05:00,OSUR,neutral
967380.0,Stocks Hitting 52-Week Highs,2014-10-16 10:25:00-04:00,OSUR,neutral
967381.0,Morning Market Movers ,2014-10-16 09:44:00-04:00,OSUR,neutral
967382.0,Benzinga's Top #PreMarket Gainers,2014-10-16 08:07:00-04:00,OSUR,positive
967383.0,Orasure Spikes Higher,2014-10-15 10:56:00-04:00,OSUR,neutral
967384.0,Upcoming Corporate Events/Presentations for the Week of Aug. 11-15th,2014-08-11 11:54:00-04:00,OSUR,neutral
967385.0,"US Stock Futures Flat Ahead Of GDP, Durable-Goods Orders Data",2014-06-25 07:47:00-04:00,OSUR,neutral
967386.0,OraSure Announces Continued Progress with Thermo Fisher on Substance Abuse Testing Business ,2014-06-25 06:08:00-04:00,OSUR,negative
967387.0,OraSure Technologies Sees Q2 Sales $26.0M-26.50M vs $26.21M Est; Reaffirms Outlook,2014-06-25 06:08:00-04:00,OSUR,neutral
967388.0,OraSure Technologies Sees Q2 EPS $0.01-0.02 vs $(0.09) Est; Reaffirms Outlook,2014-06-25 06:05:00-04:00,OSUR,neutral
967389.0,"Events Scheduled for Week of Jun 23rd to Jun 27th, 2014",2014-06-23 18:25:00-04:00,OSUR,neutral
967390.0,Orasure Reports New Co-Promotion Deal for OraQuick with AbbVie,2014-06-11 08:05:00-04:00,OSUR,neutral
967391.0,"Corporate Events for the Week of Jun. 2nd, 2014",2014-06-02 18:19:00-04:00,OSUR,neutral
967392.0,"OraSure Technologies, Inc. Sees Q2 EPS $0.09-0.10; Sees Sales $25.20M-25.70M",2014-05-07 16:11:00-04:00,OSUR,neutral
967393.0,"OraSure Technologies, Inc. Reports Q1 EPS of $(0.10) vs $(0.13) Est",2014-05-07 16:11:00-04:00,OSUR,neutral
967394.0,"OraSure Technologies, Inc. Sees Q1 EPS $(0.13)-(0.14) vs $(0.11) Est; Sees Sales $23.0M-23.50M vs $22.51M Est",2014-02-05 16:23:00-05:00,OSUR,neutral
967395.0,"OraSure Technologies, Inc. Reports Q4 EPS of $0.11 vs $(0.08) Est; Revenue of $28.80M vs $27.43M Est",2014-02-05 16:22:00-05:00,OSUR,neutral
967396.0,OraSure Addresses FDA Warning Letter on DNA Genotek,2014-01-07 09:54:00-05:00,OSUR,negative
967397.0,"Orasure Technologies Addresses FDA Warning Letter by DNA Genotek, Does Not See Material Effect",2014-01-07 09:54:00-05:00,OSUR,negative
967398.0,UPDATE: OraSure Technologies Said DNA Genotek Accounted for Less Than 5% of 2013 Sales,2013-11-25 15:56:00-05:00,OSUR,neutral
967399.0,"OraSure Technologies Says Customer DNA Genotek Received Warning Letter from FDA to End Marketing in US, Co. Reaffirms Q4 Outlook",2013-11-25 15:55:00-05:00,OSUR,negative
967400.0,OraSure Technologies Reaffirms Q4 2013 Guidance ,2013-11-25 15:55:00-05:00,OSUR,neutral
967401.0,OraSure Technologies Terminates Assay Collaboration Agreement with Roche Diagnostics ,2013-11-21 06:05:00-05:00,OSUR,positive
967402.0,"Stephens & Co. Downgrades OraSure Technologies, Inc. to Equalweight",2013-11-07 08:52:00-05:00,OSUR,neutral
967403.0,"OraSure Technologies, Inc. Sees Q3 EPS $(0.07)-(0.08) vs $(0.10) Est; Sees Sales $27.50M-28.0M vs $25.20M Est",2013-11-06 16:27:00-05:00,OSUR,neutral
967404.0,"OraSure Technologies, Inc. Reports Q3 EPS of $(0.03) vs $(0.10) Est; Revenue of $24.70M vs $24.21M Est",2013-11-06 16:14:00-05:00,OSUR,neutral
967405.0,"Raymond James Upgrades OraSure Technologies, Inc. to Outperform, Announces $8.00 PT",2013-09-19 09:06:00-04:00,OSUR,neutral
967406.0,"OraSure Technologies, Inc. Reports Q2 EPS of $(0.10) vs $(0.16) Est",2013-08-07 16:44:00-04:00,OSUR,neutral
967407.0,UPDATE: Cowen and Company Upgrades OraSure Following Reduced Launch Expectations,2013-07-16 11:31:00-04:00,OSUR,neutral
967408.0,"Cowen & Company Upgrades OraSure Technologies, Inc. to Outperform, Raises PT to $6.60",2013-07-16 08:48:00-04:00,OSUR,neutral
967409.0,FDA Issues Report for June 13th Panel Meeting on Flu Tests,2013-06-11 12:03:00-04:00,OSUR,negative
967410.0,"Jefferies Maintains Buy on OraSure Technologies, Inc., Lowers PT to $8.00",2013-05-31 11:21:00-04:00,OSUR,negative
967411.0,UPDATE: Jefferies Assumes Coverage on OraSure Technologies at Buy on Weaker Demand Trend Concerns,2013-05-31 11:07:00-04:00,OSUR,negative
967412.0,"Jefferies Initiates Coverage on OraSure Technologies, Inc. at Buy, Announces $8.00 PT",2013-05-31 08:39:00-04:00,OSUR,neutral
967413.0,"OraSure Technologies, Inc. Reports Q1 EPS of $(0.18), Inline; Revenue of $21.20M vs $20.82M Est",2013-05-08 16:15:00-04:00,OSUR,neutral
967414.0,Stocks Hitting 52-Week Lows,2013-04-04 10:56:00-04:00,OSUR,negative
967415.0,Stocks Hitting 52-Week Lows,2013-03-28 10:28:00-04:00,OSUR,negative
967416.0,"Stephens & Co. Initiates Coverage on OraSure Technologies, Inc. at Overweight, Announces $8.00 PT",2013-03-28 09:16:00-04:00,OSUR,negative
967417.0,Stocks Hitting 52-Week Lows,2013-02-11 10:32:00-05:00,OSUR,negative
967418.0,Stocks Hitting 52-Week Lows,2013-02-07 10:23:00-05:00,OSUR,negative
967419.0,"Jefferies Maintains Buy on OraSure Technologies, Inc., Lowers PT to $12.00",2013-02-07 08:33:00-05:00,OSUR,negative
967420.0,"OraSure Technologies, Inc. Sees Q1 EPS $(0.18)-(0.19) vs $(0.11) Est; Sees Sales $20.0M-21.0M vs $23.0M Est",2013-02-06 16:52:00-05:00,OSUR,neutral
967421.0,"OraSure Technologies, Inc. Reports Q4 EPS of $(0.11) vs $(0.14) Est",2013-02-06 16:52:00-05:00,OSUR,neutral
967422.0,"Jefferies & Company Maintains OraSure Technologies at Buy, Lowers PT from $14 to $13",2012-11-08 07:28:00-05:00,OSUR,negative
967423.0,Benzinga's Top Initiations,2012-10-16 07:45:00-04:00,OSUR,positive
967424.0,Raymond James Initiates Coverage OraSure Technologies at Market Perform,2012-10-15 16:15:00-04:00,OSUR,neutral
967425.0,"Orasure's Home HIV Test Won't Dent Virus Spread -Bloomberg, Citing Journal",2012-10-08 17:00:00-04:00,OSUR,neutral
967426.0,Cowen Initiates Coverage OraSure Technologies at Neutral,2012-10-02 08:16:00-04:00,OSUR,neutral
967427.0,Orasure Technologies Files $200M Mixed Securities Shelf,2012-09-28 17:06:00-04:00,OSUR,positive
967428.0,OraSure CEO Douglas: 'Hepatitis is 5 Times More Prevalent Than HIV',2012-09-27 18:20:00-04:00,OSUR,neutral
967429.0,OraSure CEO Douglas: 'Our Objective is to Make it Easier for People to Know HIV Status',2012-09-27 18:18:00-04:00,OSUR,positive
967430.0,OraSure CEO Douglas: 'We Began Shipping to Retailers Last Friday and Saturday',2012-09-27 18:17:00-04:00,OSUR,neutral
967431.0,Jim Cramer Interviews CEO Douglas A. Michels of OraSure Technologies on Mad Money,2012-09-27 18:16:00-04:00,OSUR,negative
967432.0,UPDATE: Citigroup Initiates OraSure Technologies at Buy,2012-09-17 07:59:00-04:00,OSUR,neutral
967433.0,"Citigroup Initiates Coverage on OraSure Technologies at Buy, Announces PT of $13",2012-09-17 06:17:00-04:00,OSUR,neutral
967434.0,Benzinga's Top Initiations,2012-08-10 07:30:00-04:00,OSUR,positive
967435.0,"UPDATE: Jefferies Initiates Buy, $14 PT on OraSure Tech on New Product Cycle  ",2012-08-10 07:22:00-04:00,OSUR,neutral
967436.0,"Jefferies & Company Initiates Coverage on OraSure Technologies at Buy, Announces PT of $14",2012-08-10 05:51:00-04:00,OSUR,neutral
967437.0,Barrington Research Upgrades OraSure Technologies from Market Perform to Outperform,2012-08-08 15:38:00-04:00,OSUR,neutral
967438.0,McNicoll Lewis Vlak Suspends Coverage on OraSure Technologies,2012-07-16 07:01:00-04:00,OSUR,neutral
967439.0,"Option Alert: Orasure Technologies August 10 Put; Block Trade: 1,870 Contracts; Currently $12.33",2012-07-11 09:57:00-04:00,OSUR,negative
967440.0,OraSure Technologies Announces Proposed Public Offering of Common Stock,2012-07-09 16:31:00-04:00,OSUR,neutral
967441.0,"Canaccord Genuity Reiterates OraSure Technologies at Buy, Reiterates PT at $14",2012-07-06 08:36:00-04:00,OSUR,neutral
967442.0,Stocks To Watch For July 6,2012-07-06 04:25:00-04:00,OSUR,neutral
967443.0,From Earlier: Barrington Research Downgrades OraSure Technologies on Valuation,2012-07-05 14:45:00-04:00,OSUR,neutral
967444.0,Barrington Research Downgrades OraSure Technologies from Outperform to Market Perform,2012-07-05 14:38:00-04:00,OSUR,neutral
967445.0,Benzinga's Top Pre-Market Gainers,2012-07-05 08:11:00-04:00,OSUR,positive
967446.0,OraSure Technologies up 5% on FDA Approval,2012-07-03 12:47:00-04:00,OSUR,positive
967447.0,OraSure Technologies Resumes Trading,2012-07-03 12:45:00-04:00,OSUR,neutral
967448.0,PREVIEW: OraSure Technologies to Resume Trading at 12:45pm,2012-07-03 12:30:00-04:00,OSUR,neutral
967450.0,OraSure Wins FDA Approval for OraQuick In-Home HIV Test -Bloomberg,2012-07-03 12:15:00-04:00,OSUR,positive
967451.0,OraSure Technologies Halted Pending News,2012-07-03 12:12:00-04:00,OSUR,neutral
967452.0,OraSure Technologies up 19% on Positive FDA Recommendation,2012-05-16 11:02:00-04:00,OSUR,positive
967453.0,OraSure Technologies Rises 35% Pre-Market on Tuesday's 17-0 FDA Panel Vote on Home HIV Test,2012-05-16 08:04:00-04:00,OSUR,neutral
967454.0,OraSure Technologies to Resume Trading at 6:25pm,2012-05-15 18:03:00-04:00,OSUR,neutral
967455.0,FDA Panel Votes 17-0 That Orasure at-Home HIV Test is Safe and Effective,2012-05-15 16:40:00-04:00,OSUR,positive
967456.0,FDA Panel: Benefits Of OraSure Home HIV Test Outweigh Risks,2012-05-15 16:32:00-04:00,OSUR,positive
967457.0,OraSure Technologies Halted; FDA Panel Meets Today to Vote on OraQuick In-Home HIV Test,2012-05-15 07:43:00-04:00,OSUR,neutral
967458.0,OraSure Technologies Halted; Pending News,2012-05-15 07:02:00-04:00,OSUR,neutral
967459.0,FDA Says OraSure's HIV Test Has Public Health Value,2012-05-11 09:05:00-04:00,OSUR,positive
967460.0,OraSure Technologies Reports Q1 EPS $-0.07 vs $-0.08 Est; Revenues $20.9M vs $20.94M Est,2012-05-02 16:25:00-04:00,OSUR,neutral
967461.0,FDA Sets Date for Advisory Committee Review of OraSure Over-the-Counter Rapid HIV Test,2012-04-04 10:50:00-04:00,OSUR,neutral
967462.0,Complete Genomics Now Accepts DNA Obtained From Saliva for Whole Human Genome Sequencing ,2012-03-29 08:06:00-04:00,OSUR,positive
967463.0,Weekly Traders Homework: Oil Is The Hot Theme (w/ Economic Calendar and Stock Radar),2012-02-27 00:26:00-05:00,OSUR,neutral
967464.0,OraSure Technologies Reports Q4 EPS $0.00 vs $(0.05) Est; Revenues $23.7M vs $23.08M Est			 ,2012-02-08 16:14:00-05:00,OSUR,neutral
967465.0,A Peek Into The Market Before The Trading Starts,2012-01-03 07:33:00-05:00,OSUR,neutral
967466.0,OraSure Makes Final FDA Submission for Approval of Over-the-Counter Rapid HIV Test ,2012-01-03 06:58:00-05:00,OSUR,positive
967467.0,Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar),2011-12-11 23:22:00-05:00,OSUR,neutral
967468.0,Orasure Gets FDA 510(K) Clearance for Oragene DX Collection -Bloomberg,2011-12-08 06:29:00-05:00,OSUR,negative
967469.0,"CEOWORLD Top Medical Equipment and Supplies stocks- ELOS, FLDM, SURG, WWIN, KH, OSUR, AIS, TRNX, DCTH, ICUI",2011-05-02 14:38:00-04:00,OSUR,positive
967470.0,OraSure Technologies Hits 52-Week High (OSUR),2011-04-08 11:46:00-04:00,OSUR,neutral
967471.0,Sure Or OSUR? (OSUR),2010-11-22 11:43:00-05:00,OSUR,positive
967472.0,OraSure Announces 2010 Third Quarter Financial Results: EPS of $0.01,2010-11-09 16:03:00-05:00,OSUR,neutral
967473.0,"Benzinga’s Top Pre-Market Losers (JDSU, OSUR, MKTAY, COST, VOD)",2010-05-06 09:11:00-04:00,OSUR,negative
967474.0,ThinkEquity Is Bullish On OraSure Technologies (OSUR),2010-04-09 13:23:00-04:00,OSUR,neutral
967475.0,"ThinkEquity Reiterates Buy on OraSure Technologies (OSUR, MRK, PFE)",2010-03-08 12:29:00-05:00,OSUR,neutral
967476.0,"OraSure Technologies, Inc. (OSUR) Fourth-Quarter Results Beat Estimates",2010-02-11 14:18:00-05:00,OSUR,neutral
967477.0,OSUR May Launch Several Products Over the Next 12-18 Months,2009-11-19 13:32:00-05:00,OSUR,neutral
967478.0,"Benzinga’s Top Upgrades (STT, CMS, SINA, ITW, OSUR, MRX)",2009-11-17 10:46:00-05:00,OSUR,positive
